Rosen Law Firm Launches Investigation Into NUAI Following Short Seller Allegations

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Rosen Law Firm investigates NUAI following short seller allegations of questionable spending priorities and CEO's penny stock history. Stock fell 6.9%.

Rosen Law Firm Launches Investigation Into NUAI Following Short Seller Allegations

The Rosen Law Firm has initiated a securities investigation into New Era Energy & Digital, Inc. (NASDAQ: NUAI) in response to a report released by short seller Fuzzy Panda Research that raised concerns about the company's financial priorities and management background. According to the report, NUAI allocated 2.5 times more capital toward stock promotions than its core operating expenses, raising questions about resource allocation. Additionally, the report highlighted CEO E. Will Gray II's prior involvement with penny stock ventures.

The market reacted sharply to the allegations, with NUAI shares declining 6.9% on December 12, 2025, the day the short seller report became public. The significant single-day decline reflects investor concerns about the allegations' implications for the company's operational viability and governance practices.

Investors who have experienced losses in NUAI stock are being encouraged to contact the firm to discuss potential legal remedies. The investigation seeks to determine whether securities laws or regulations governing disclosure and corporate conduct may have been violated.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 15

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON